Despite support from both parties, the Bureau of Prisons rarely approves a compassionate release request intended to allow frail and sick patients to die outside of prison. In other public health news: ears, blood pressure, the flu, selfies and raw water.
from Kaiser Health News http://ift.tt/2Fo8Wso
March 07, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Potential Competitor To Genomic Sequencing Giant Illumina Emerges From ChinaIf the Chinese company's technology can do what executives say it can, then the competition it brings into the marketplace could drive down the already-plummeting cost of genome sequencing. Other industry news focuses on hosp… Read More
HHS, Homeland Security Were Taken By Surprise When ‘Zero Tolerance’ Policy Was Implemented, Report FindsThe lack of advance notice left the agencies scrambling to deal with the increase in detained children, the Government Accountability Office report found. The report also noted that the absence of a central database for the m… Read More
Former Surgeon Generals Discuss How They Were Muzzled Over Unpopular Health Ideas — Only To Later Be Proven RightDr. Antonia C. Novello, Dr. M. Joycelyn Elders, Dr. David Satcher and Dr. Richard Carmona spoke about their tenures as surgeon general, and the importance of impartial public health officials with authority. from Kaiser Heal… Read More
Health Advisory Group Recommends Hepatitis A Shots For Homeless As Outbreaks IncreaseThe panel's unanimous recommendation to vaccinate against the contagious liver disease would make it easier for health care workers who serve the homeless to offer hepatitis A shots along with other services. The panel draws … Read More
Amgen To Slash Cholesterol Drug Price By 60 Percent After Years Of Struggling To Gain Foothold In MarketThe new $5,850 a year price tag is still higher than cost-effectiveness watchdogs recommend, but it's a big drop from the original $14,000 a year. Sales never took off for the drug, in part because patients balked at the cost… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment